Literature DB >> 28219965

A Public Health Response to Opioid Use in Pregnancy.

Stephen W Patrick, Davida M Schiff.   

Abstract

The use of opioids during pregnancy has grown rapidly in the past decade. As opioid use during pregnancy increased, so did complications from their use, including neonatal abstinence syndrome. Several state governments responded to this increase by prosecuting and incarcerating pregnant women with substance use disorders; however, this approach has no proven benefits for maternal or infant health and may lead to avoidance of prenatal care and a decreased willingness to engage in substance use disorder treatment programs. A public health response, rather than a punitive approach to the opioid epidemic and substance use during pregnancy, is critical, including the following: a focus on preventing unintended pregnancies and improving access to contraception; universal screening for alcohol and other drug use in women of childbearing age; knowledge and informed consent of maternal drug testing and reporting practices; improved access to comprehensive obstetric care, including opioid-replacement therapy; gender-specific substance use treatment programs; and improved funding for social services and child welfare systems. The American College of Obstetricians and Gynecologists supports the value of this clinical document as an educational tool (December 2016).
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 28219965     DOI: 10.1542/peds.2016-4070

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  43 in total

Review 1.  Children in the Opioid Epidemic: Addressing the Next Generation's Public Health Crisis.

Authors:  Kenneth A Feder; Elizabeth J Letourneau; Jody Brook
Journal:  Pediatrics       Date:  2018-12-04       Impact factor: 7.124

2.  Neonatal Abstinence Syndrome In The United States, 2004-16.

Authors:  Ashley A Leech; William O Cooper; Elizabeth McNeer; Theresa A Scott; Stephen W Patrick
Journal:  Health Aff (Millwood)       Date:  2020-05       Impact factor: 6.301

3.  Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.

Authors:  Catalina N Rey; Gary J Badger; Heidi S Melbostad; Deborah Wachtel; Stacey C Sigmon; Lauren K MacAfee; Anne K Dougherty; Sarah H Heil
Journal:  Contraception       Date:  2020-02-01       Impact factor: 3.375

4.  Improving Public Health Systems for Substance-Affected Pregnancies.

Authors:  Stephen W Patrick
Journal:  Am J Public Health       Date:  2019-01       Impact factor: 9.308

5.  Opioid Use Disorder Treatment Facilities With Programs for Special Populations.

Authors:  Scott E Hadland; Victoria A Jent; Rachel H Alinsky; Brandon D L Marshall; Pia M Mauro; Magdalena Cerdá
Journal:  Am J Prev Med       Date:  2020-05-21       Impact factor: 5.043

6.  Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.

Authors:  Eric S Hall; Scott L Wexelblatt; James M Greenberg
Journal:  Popul Health Manag       Date:  2018-02-27       Impact factor: 2.459

7.  Hospital Variation in Child Protection Reports of Substance Exposed Infants.

Authors:  Rebecca Rebbe; Joseph A Mienko; Emily Brown; Ali Rowhani-Rahbar
Journal:  J Pediatr       Date:  2019-02-13       Impact factor: 4.406

8.  Amphetamine- and Opioid-Affected Births: Incidence, Outcomes, and Costs, United States, 2004-2015.

Authors:  Lindsay K Admon; Gavin Bart; Katy B Kozhimannil; Caroline R Richardson; Vanessa K Dalton; Tyler N A Winkelman
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

9.  Trends in heroin use among women of reproductive age in the United States, 2004-2017.

Authors:  Alyssa Vanderziel; Maria A Parker; Omayma Alshaarawy
Journal:  Addict Behav       Date:  2020-06-22       Impact factor: 3.913

Review 10.  Consensus Guidelines and State Policies: The Gap Between Principle and Practice at the Intersection of Substance Use and Pregnancy.

Authors:  Laura J Faherty; Bradley D Stein; Mishka Terplan
Journal:  Am J Obstet Gynecol MFM       Date:  2020-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.